MC

MARCELA SALGADO MD, CCRP

Clinical Development/operations Lead at BriaCell Therapeutics

Marcela Salgado MD, CCRP has a diverse and extensive work experience in various roles related to clinical research and regenerative medicine. MARCELA'smost recent position is as a Clinical Operations Manager at BriaCell Therapeutics Corp. where they began in July 2022. Prior to this, they served as the President of Research and Development in Regenerative Medicine at Optimal Cell Biotech Inc since 2016.

In their previous positions, Marcela worked at the University of Miami as a Senior Clinical Regulatory Specialist and Clinical Project Manager from February 2021 to February 2023. Before that, they were a Medical Writing Specialist at Apyx Medical from March 2022 to June 2022.

Marcela's experience also includes roles at the University of Miami Miller School of Medicine, where they served as a Senior Regulatory Specialist-Research Administrator from June 2017 to December 2019. MARCELA was also the Medical Regulatory and Compliance Director at Gentera Center for Regenerative Medicine from October 2016 to June 2017.

Additionally, Marcela worked as a Medical Research Administrator at Great HealthWorks from September 2015 to October 2016, and as an Assistant Scientist and Senior CRC/REG Specialist at the University of Miami/Miller School of Medicine from 2009 to 2015.

Prior to their positions in the United States, Marcela held the role of Lead Clinical Research Coordinator at Miami Research Associates LLC from September 2012 to March 2013. MARCELA also worked as an Assistant Professor and Clinical Research Assistant at South Colombian University (USCO) from 2008 to 2009.

Marcela Salgado MD, CCRP has a diverse education history. MARCELA attended the Universidad El Bosque to earn their Doctor of Medicine (M.D.) degree, although the specific years of their enrollment were not provided. Additionally, they completed the USMLE Step 1 and 2 exams at KAPLAN MEDICAL from 2007 to 2008.

Marcela also pursued further education at the University of Miami Miller School of Medicine from 2009 to 2012. Here, they obtained a degree from the CITI Collaborative Institutional Training Initiative, which focused on Good Clinical Practice, Human Research Subjects, and FDA Regulation.

While Marcela's education history does not mention any specific certifications from an institution, it is worth noting that they have some additional training or knowledge in public health. However, the exact details of this certification, including the institution and when it was obtained, are not provided.

Lastly, there is mention of Marcela Salgado considering enrollment at Duke University School of Medicine, but no degree or field of study is specified.

Links